PHARMACYTE BIOTECH, INC. Interest and Other Income
PHARMACYTE BIOTECH, INC. (PMCB) reported Interest and Other Income of $22 for the 3-month period ending 2015-01-31, per its 10-Q filed 2015-03-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2015-03-13
- PHARMACYTE BIOTECH, INC. interest and other income for the quarter ending 2015-01-31 was $22.00, a 85.23% decline year-over-year.
- PHARMACYTE BIOTECH, INC. interest and other income for the quarter ending 2014-10-31 was $508.00, a 334.19% increase year-over-year.
- PHARMACYTE BIOTECH, INC. interest and other income for the quarter ending 2014-07-31 was $988.00.
- PHARMACYTE BIOTECH, INC. interest and other income for the quarter ending 2014-04-30 was $824.00.
- PHARMACYTE BIOTECH, INC. interest and other income for fiscal 2014 was $1.09K.
- PHARMACYTE BIOTECH, INC. interest and other income for fiscal 2013 was $0.00.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2015-01-31 | $22.00 10-Q · filed 2015-03-13 | $530.00 derived: sum of 2 quarters · filed 2015-03-13 | $1.52K 10-Q · filed 2015-03-13 | $2.34K derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-10-31 | $508.00 10-Q · filed 2014-12-15 | $1.50K 10-Q · filed 2014-12-15 | $2.32K derived: sum of 3 quarters · filed 2014-12-15 | $2.47K derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-07-31 | $988.00 10-Q · filed 2014-09-15 | $1.81K derived: sum of 2 quarters · filed 2014-09-15 | $1.96K derived: sum of 3 quarters · filed 2015-03-13 | $2.08K derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-04-30 | $824.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-04 | $973.00 derived: sum of 2 quarters · filed 2015-03-13 | $1.09K derived: sum of 3 quarters · filed 2015-03-13 | $1.09K 10-K · filed 2014-08-04 |
| 2014-01-31 | $149.00 10-Q · filed 2015-03-13 | $266.00 derived: sum of 2 quarters · filed 2015-03-13 | $266.00 10-Q · filed 2015-03-13 | $266.00 derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-10-31 | $117.00 10-Q · filed 2014-12-15 | $117.00 10-Q · filed 2014-12-15 | $117.00 derived: sum of 3 quarters · filed 2014-12-15 | $117.00 derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | $0.00 10-Q · filed 2014-09-15 | $0.00 derived: sum of 2 quarters · filed 2014-09-15 | $0.00 derived: sum of 3 quarters · filed 2014-09-15 | $0.00 derived: sum of 4 quarters · filed 2014-09-15 |
| 2013-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-04 | $0.00 derived: sum of 2 quarters · filed 2014-08-04 | $0.00 derived: sum of 3 quarters · filed 2014-08-04 | $0.00 10-K · filed 2014-08-04 |
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | |
| 2012-10-31 | $0.00 10-Q · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |